Showing results (1451-1460 of 1,507) with videos related to

Sort By:
Pageof 151
Science (New York, N.Y.)|November 22, 1996
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide searchJ R Smith, D Freije, J D Carpten, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide associationKarl C Desch, Ayse B Ozel, David Siemieniak, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2009
HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivativesGuangyi Wang, Huoxing Lei, Xiaofang Wang, et al.
Stroke|September 11, 2012
Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease riskTatiana Foroud, Daniel L Koller, Dongbing Lai, et al.
Human Genetics|December 6, 2005
Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effectBao-Li Chang, Ethan M Lange, Latchezar Dimitrov, et al.
Frontiers in Genetics|July 29, 2015
Ancestry of the Timorese: age-related macular degeneration associated genotype and allele sharing among human populations from throughout the worldMargaux A Morrison, Tiago R Magalhaes, Jacqueline Ramke, et al.
American Journal of Human Genetics|July 5, 2003
Localization of a novel melanoma susceptibility locus to 1p22Elizabeth Gillanders, Suh-Hang Hank Juo, Elizabeth A Holland, et al.
Cancer Research|May 19, 2007
EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activityHaris Vikis, Mitsuo Sato, Michael James, et al.
Cancer Research|January 11, 2007
Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1Min Wang, Haris G Vikis, Yian Wang, et al.
The Lancet. Haematology|March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trialDavid I Marks, Amy A Kirkwood, Clare J Rowntree, et al.
Pageof 151